Drg Intl., Inc.

Drg Intl., Inc. — FDA 510(k) Submissions

Drg Intl., Inc. has submitted 4 FDA 510(k) premarket notifications since 2000, of which 4 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Radioimmunoassay, Testosterones And Dihydrotestosterone, Enzyme Immunoassay, Cortisol, Salivary, Radioimmunoassay, 17-hydroxyprogesterone . Use the specialty filter in the sidebar to narrow results.